undamentalytics Newsletter
Sign in

Whitehawk Therapeutics, Inc. revenue

Whitehawk Therapeutics, Inc.'s revenue was $7.1m in fiscal 2025, down 72.5% on the year before. Since fiscal 2018 ($20.2m) it has grown at a compound -13.8% a year. Over the last twelve months it was $0.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue200141415242670
Growth on the year before—−100.0%—0.0%+8.7%+60.1%+6.7%−72.5%—
Gross profit———1414222360
Gross margin———100.0%91.2%88.5%88.4%89.4%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Whitehawk Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Whitehawk Therapeutics, Inc.